EP3914617
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.1.2020:
13.3.2024:
20708762.8
:
23.1.2040
:
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
24.1.2020
13.3.2024
:
Alexion Pharmaceuticals, Inc.:
121 Seaport Boulevard, Boston, MA 02210, US
:
PAYTON, Lori:
Madison, CT 06443, US
:
MIX, Christian:
Wellesley, MA 02481, US
:
PRADHAN, Rajendra:
New Haven, CT 06510, US
:
DAMOKOSH, Andrew:
Hartford, CT 06107, US
:
SWENSON, Eugene Scott:
Madison, CT 06443, US
:
GAO, Xiang:
Guilford, CT 06437, US
:
201962796953 P:
25.1.2019:
US
:
US2020014998:
24.1.2020
:
C07K 16/18, A61P 7/00, C07K 16/40, C07K 16/28, C07K 16/46